Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells

Journal of Neuro-Oncology

Volumn 116, Issue 1, 2014, Pages 41-48

  Cong, Zi Xiang ^a   Wang, Han Dong ^a   Zhou, Yuan ^a   Wang, Jia Wei ^a   Pan, Hao ^a   Zhang, Ding Ding ^a   Zhang, Li ^a   Zhu, Lin ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Chemoradiotherapy resistance; Glioblastoma; Irradiation; Nrf2; Temozolomide

Indexed keywords

TEMOZOLOMIDE; TRANSCRIPTION FACTOR NRF2;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL VIABILITY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RADIOSENSITIVITY; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; TUMOR GENE;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL LINE, TUMOR; DACARBAZINE; DOWN-REGULATION; FEMALE; GLIOBLASTOMA; HEME OXYGENASE-1; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; RADIATION; RNA, MESSENGER;

EID: 84891769614     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1260-x     Document Type: Article

References (28)

1. Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD (2008) Dual roles of Nrf2 in cancer. Pharmacol Res 58:262-270. doi: 10.1016/j.phrs.2008.09.003
2. Lee JM, Johnson JA (2004) An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 37:139-143
3. Niture SK, Kaspar JW, Shen J, Jaiswal AK (2010) Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 244:37-42. doi: 10.1016/j.taap.2009.06.009
4. Akhdar H, Loyer P, Rauch C, Corlu A, Guillouzo A, Morel F (2009) Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Eur J Cancer 45:2219-2227. doi: 10.1016/j.ejca.2009.05.017
5. Singh A, Bodas M, Wakabayashi N, Bunz F, Biswal S (2010) Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid Redox Signal 13:1627-1637. doi: 10.1089/ars 2010.3219
6. Cho JM, Manandhar S, Lee HR, Park HM, Kwak MK (2008) Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance. Cancer Lett 260:96-108. doi: 10.1016/j.canlet.2007.10.022
7. Homma S, Ishii Y, Morishima Y, Yamadori T, Matsuno Y, Haraguchi N, Kikuchi N, Satoh H, Sakamoto T, Hizawa N, Itoh K, Yamamoto M (2009) Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res 15:3423-3432. doi: 10.1158/1078-0432.CCR-08-2822
8. Kweon MH, Adhami VM, Lee JS, Mukhtar H (2006) Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem 281:33761-33772. doi: 10.1074/jbc.M604748200
9. Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y, Chen W, Yi X, Zheng W, Wondrak GT, Wong PK, Zhang DD (2008) Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235-1243. doi: 10.1093/carcin/bgn095
10. Jin W, Wang H, Yan W, Xu L, Wang X, Zhao X, Yang X, Chen G, Ji Y (2008) Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm 2008:725174. doi: 10.1155/2008/725174
11. Ma ZC, Hong Q, Wang YG, Tan HL, Xiao CR, Liang QD, Zhang BL, Gao Y (2010) Ferulic acid protects human umbilical vein endothelial cells from radiation induced oxidative stress by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Biol Pharm Bull 33:29-34. doi: 10.1248/bpb.33.29
12. Lee S, Lim MJ, Kim MH, Yu CH, Yun YS, Ahn J, Song JY (2012) An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses. Free Radic Biol Med 53:807-816. doi: 10.1016/j.freeradbiomed.2012.05.038
13. Das A, Banik NL, Patel SJ, Ray SK (2004) Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer 3:36. doi: 10.1186/1476-4598-3-36
14. Wang X, de Rivero Vaccari JP, Wang H, Diaz P, German R, Marcillo AE, Keane RW (2011) Activation of the nuclear factor E2-related factor 2/antioxidant response element pathway is neuroprotective after spinal cord injury. J Neurotrauma 29:936-945. doi: 10.1089/neu 2011.1922
15. Wang JW, Wang HD, Zhong WZ, Li N, Cong ZX (2012) Expression and cell distribution of metabotropic glutamate receptor 5 in the rat cortex following traumatic brain injury. Brain Res 1464:73-81. doi: 10.1016/j.brainres.2012.05. 014
16. Pan H, Wang H, Zhu L, Mao L, Qiao L, Su X (2011) The Role of Nrf2 in Migration and Invasion of Human Glioma Cell U251. World Neurosurg. doi: 10.1016/j.wneu.2011.06.063
17. Zhang DD (2010) The Nrf2-Keap1-ARE signaling pathway: the regulation and dual function of Nrf2 in cancer. Antioxid Redox Signal 13:1623-1626. doi: 10.1089/ars 2010.3301
18. Zhou Y, Wang HD, Zhu L, Cong ZX, Li N, Ji XJ, Pan H, Wang JW, Li WC (2013) Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line. Oncol Rep 29:394-400. doi: 10.3892/or 2012.2115
19. McDonald JT, Kim K, Norris AJ, Vlashi E, Phillips TM, Lagadec C, Della Donna L, Ratikan J, Szelag H, Hlatky L, McBride WH (2010) Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res 70:8886-8895. doi: 10.1158/0008-5472.can-10-0171
20. Shim GS, Manandhar S, Shin DH, Kim TH, Kwak MK (2009) Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway. Free Radic Biol Med 47:1619-1631. doi: 10.1016/j.freeradbiomed. 2009.09.006
21. Wang XJ, Hayes JD, Wolf CR (2006) Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of Nrf2 by cancer chemotherapeutic agents. Cancer Res 66:10983-10994. doi: 10.1158/0008-5472.CAN-06-2298
22. Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7:97-110. doi: 10.1016/j.drup.2004. 01.004
23. Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579-591. doi: 10.1038/nrd2803
24. Wallace SS (1998) Enzymatic processing of radiation-induced free radical damage in DNA. Radiat Res 150:S60-S79
25. Kang KA, Lee IK, Zhang R, Piao MJ, Kim KC, Kim SY, Shin T, Kim BJ, Lee NH, Hyun JW (2010) Radioprotective effect of geraniin via the inhibition of apoptosis triggered by γ-radiation-induced oxidative stress. Cell Biol Toxicol 27:83-94. doi: 10.1007/s10565-010-9172-4
26. Phillips TM, McBride WH, Pajonk F (2006) The Response of CD24-/low/CD44+breast cancer-initiating cells to radiation. J Natl Cancer Inst 98:1777-1785. doi: 10.1093/jnci/djj495
27. Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, Lin YF, Shih CM (2012) Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radic Biol Med 52:377-391. doi: 10.1016/j.freeradbiomed.2011.10.487
28. Konstantinopoulos PA, Spentzos D, Fountzilas E, Francoeur N, Sanisetty S, Grammatikos AP, Hecht JL, Cannistra SA (2011) Keap1 mutations and Nrf2 pathway activation in epithelial ovarian. Cancer Res 71:5081-5089. doi: 10.1158/0008-5472.CAN-10-4668